Streetbeat News

Analyst Ratings

CRWD

Cantor Fitzgerald analyst Yi Fu Lee has reiterated an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintained a price target of $350.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:29 pm

SRPT

RBC Capital has reiterated its 'Outperform' rating for Sarepta Therapeutics, maintaining a price target of $181. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:23 pm

GTY

JP Morgan analyst Anthony Paolone maintains a Neutral rating on Getty Realty (NYSE:GTY) but raises the price target from $31 to $33.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:23 pm

CRWD

Susquehanna analyst Shyam Patil maintains a positive outlook on CrowdStrike Holdings, keeping the price target at $310.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:21 pm

AAPL

Needham analyst Laura Martin reiterates a Buy rating and $260 price target for Apple, highlighting advertising as a potential growth catalyst amid concerns over iPhone 16 demand. Martin suggests Apple's slow revenue growth is a concern, and advertising could boost growth and profit margins.

Portfolio Pulse from Chris Katje

September 19, 2024 | 2:20 pm

KMX

JP Morgan analyst Rajat Gupta maintains an Underweight rating on CarMax (NYSE:KMX) but raises the price target from $55 to $65.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2024 | 2:18 pm

DELL

Unusual options activity has been detected for Dell Technologies (NYSE:DELL), with a mix of bullish and bearish sentiment among major investors. The options trades suggest a price target range of $105 to $170. Analysts maintain positive ratings with an average price target of $154.6.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 2:17 pm

CVX

Recent options activity for Chevron (NYSE:CVX) shows a bearish sentiment with 55% of trades being bearish. The trading volume and open interest suggest a focus on a price range between $135 and $160. Despite this, analysts maintain a positive outlook with a target price of $189.

Portfolio Pulse from Benzinga Insights

September 19, 2024 | 2:17 pm